All the news Showing 10 of 189 articles from: Disease course and symptomsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources 8 reports on liver cancer outcomes with HCV, DAA therapy Healio Hepatology / 12 April 2018 Higher vitamin D concentration lowers risk for overall, liver cancer Healio / 14 March 2018 HCV hospitalizations increasing among baby boomers, men, drug users Healio / 12 February 2018 HCV Can Reactivate with Treatment of Non-hepatic Cancer MD Magazine / 05 February 2018 Secondary liver cancer after colorectal cancer more common in people with chronic hepatitis B Keith Alcorn / 22 January 2018 The spread of cancer from the bowel to the liver – metastasis – is more likely to occur in people with chronic hepatitis B infection, a Chinese study published in ... Liver cancer incidence after HCV therapy linked to risk factors, not treatment Healio Hepatology / 11 December 2017 Elevated HBV surface antigen, viral load increases liver cancer risk Healio Hepatology / 06 December 2017 Nivolumab improves outcomes in liver cancer study Liz Highleyman / 13 November 2017 Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumour size or disease stabilisation in people with hepatocellular carcinoma (HCC) in the CheckMate ... Curing hepatitis C with DAAs linked to 71% reduction in liver cancer Liz Highleyman / 30 October 2017 People who achieved a sustained response to hepatitis C treatment lowered their risk of hepatocellular carcinoma by around 70%, regardless of whether they were treated with new direct-acting antivirals (DAAs) or older interferon-based therapy, ... HCV clearance lowers liver cancer risk by 70% no matter drug of choice Healio / 25 October 2017 ← Prev1...23456...19Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive